期刊文献+

煤工尘肺合并COPD使用舒利迭治疗研究 被引量:5

Effect of Seretide in the treatment of coal workers with pneumoconiosis complicated with COPD
下载PDF
导出
摘要 目的评价长期规则使用舒利迭对煤工尘肺合并COPD患者的临床疗效。方法选择本院的80例煤工尘肺合并COPD的患者,随机分成观察者、对照组。对照组予吸氧、解痉平喘、止咳化痰等一般治疗,共2年。观察者在以上治疗基础满1年后,再加舒利迭长期吸入,治疗1年。每2月行一次肺功能检测,记录每次急性发作的持续时间。结果比较肺功能、急性加重次数及平均每次急性加重持续的时间。第一年,两组无显著差异。第二年,观察组以上指标都明显改善,有统计学意义。对照组肺功能较一年前数值有所下降,急性加重次数及平均持续时间略有增加,P>0.05。两组对照有显著差异,P<0.05。结论长期吸入舒利迭,能改善煤工尘肺合并COPD的肺功能,能延长其缓解期。 Objective To evaluate the clinical curative effect of long-term regular use of Seretide in the treatment of coal workers with pneumoconiosis complicated with chronic obstructive pulmonary disease(COPD).Methods 80 coal workers with pneumoconiosis complicated with COPD were randomly divided into two groups.All patients were treated with oxygen,antispasmodic and asthma relieve,cough and phlegm relieve and other general treatment,and the treatment course were 2 years.1-year after the treatment,the observation group was additionally treated with Seretide inhalation for 1 year.Pulmonary function was tested and compared every two months,and the duration of acute attack was recorded.Results There was no significant difference between the two groups at the first year.The improvement of the above mentioned indicators was more pronounced in the observation group than in the control group at the second year(P 0.05).Conclusion Long-term regular Seretide inhalation can improve their pulmonary function and prolong their remission stage in the treatment of coal workers with pneumoconiosis complicated with COPD.
出处 《临床肺科杂志》 2013年第7期1229-1231,共3页 Journal of Clinical Pulmonary Medicine
关键词 煤工尘肺 慢性阻塞性肺疾病 沙美特罗 氟替卡松 临床疗效 coal workers with pneumoconiosis chronic obstructive pulmonary disease(COPD) Seretide clinical curative effect
  • 相关文献

参考文献5

二级参考文献18

  • 1吴庆生,温继惠,曹坤波,刘世明,宋守琴,张维东,曹庆松,张学德,曹守维.低矽煤工尘肺肺气肿的特点及其发病机理[J].中华劳动卫生职业病杂志,1995,13(2):78-80. 被引量:2
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 4Howarth PH, Beckett P, Dahl R. The effect of long, acting, beta2-ag- onist on airway inflammation in asthmatic patients. Respir Med, 2000,94 Suppl F :22 - 27.
  • 5Baraniuk JN, A liM, Brody D, et al. Glucocorticosteroids induce B2- a drenergic receptor function in human nasalmucosa [ J ]. Am J Re- spir Crit Care Med, 1997,155:704 - 710.
  • 6蔡柏蔷.呼吸内科学-高级医师案头丛书[M].北京:中国协和医科大学出版社,2000.325-346.
  • 7GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 8Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 9Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 10冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.

共引文献8254

同被引文献40

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部